United States · 
What does Delos Capital invest in?
Delos Capital invests most often at Series B and Series C (64% of the rounds on record), in sectors such as Connected-health, E-health and Mental Health.
Delos Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series C: 64% of its rounds
- 03
Sole investor in 2 rounds, median $17M
What they do
Delos Capital is a private equity firm based in New York CityFrom their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Series ASeries BGrowth
- Sectors
- Connected-healthE-healthMental Health
- Based in
- Boston, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first11 appearances
- 2026
1 round
- Jun
- 2024
2 rounds
- Nov
- May
- 2019
4 rounds
- Dec
- Nov
- Sept
- Jun
- 2016
1 round
- Jun
- 2015
3 rounds
- Nov
- Aug
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
CCChi Chuan ChenDirector of Delos Capital Advisors LLC (02/2017); Manager of Delos Capital GP III, LLC (11/2021)iForm ADV
EKEileen KavanaghChief Compliance OfficeriForm ADV
HLHenry Lin ChenDirector of Delos Advisors Limited; Director of Delos Capital Advisors LLCiForm ADV
MRMatthew Robert ConstantinoChief Investment OfficeriForm ADV
MLMike Louis AmbrosioChief Financial OfficeriForm ADV
We also hold 19 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$652Massets it manages, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Delos Advisors Limited
- SEC number
- CRD 320761
Funds on its Form ADV
7 private funds, $298M in gross assets · filed Aug 2024
- Delos Investment Fund II, L.P.Private equity28 investors$238M
- Delos Investment Fund, L.P.Private equity34 investors$30M
- Delos USF Co-Investors, L.P.Private equity2 investors$15M
- Delos LSI Co-Investors, L.P.Private equity2 investors$8.1M
- Delos USF Co-Investors II L.P.Private equity1 investor$5.0M
- Delos USF Lender Co-Investor L.P.Private equity2 investors$1.9M
- Delos Pioneer Co-Investors, L.P.Private equity2 investors$463K
What they claim to have backed
From their own portfolio page (on their website)
9 of 24 we have independently watched raise
Atia Accommodating intraocularCuramir Genetic medicineEccogene Leading platformEnsoma In vivoImperative Interventional strokeInstylla Next-generation liquidRejoni A solutionSTRM.BIO Novel geneTRexBio Advancing aAllecra Novel treatmentAlpha-9 Oncology TargetedAltrubio Clinical stageApbioincCardurion Pharmaceuticals DevelopingClover Biopharmaceuticals I/OCuratia Interventional vascular productsHemo A leadingIntrinsic Spinal implantsLipoSeuticals Enhancement ofPhanes Therapeutics InnovativeSirius Therapeutics LeadingTruvic Innovative solutionsTulavi Neuro-modulation toVerge Medical Aorto-ostial
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it bought
Acquisitions by the firm itself
FCA PackagingUndisclosedJan 2015